202 related articles for article (PubMed ID: 6600195)
21. Induction of "innocent bystander" cytotoxicity in nonimmune mice by adoptive transfer of L3T4+ Lyt-1+2- mammary tumor immune T-cells.
Paul RD; Lopez DM
Cancer Res; 1987 Feb; 47(4):1105-10. PubMed ID: 2879623
[TBL] [Abstract][Full Text] [Related]
22. Rat mammary adenocarcinoma 13762 expressing IFN-gamma elicits antitumor CD4+ MHC class II-restricted T cells that are cytolytic in vitro and tumoricidal in vivo.
Frey AB
J Immunol; 1995 May; 154(9):4613-22. PubMed ID: 7722313
[TBL] [Abstract][Full Text] [Related]
23. Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression.
Ting CC; Rodrigues D
J Natl Cancer Inst; 1982 Oct; 69(4):867-72. PubMed ID: 6214653
[TBL] [Abstract][Full Text] [Related]
24. OK-432-mediated augmentation of antitumor immunity and generation of cytotoxic T lymphocytes.
Ujiie T
Jpn J Exp Med; 1987 Apr; 57(2):103-15. PubMed ID: 3499533
[TBL] [Abstract][Full Text] [Related]
25. Antitumor effect of Nocardia rubra cell wall skeleton on syngeneically transplanted P388 tumors.
Izumi S; Ogawa T; Miyauchi M; Fujie K; Okuhara M; Kohsaka M
Cancer Res; 1991 Aug; 51(15):4038-44. PubMed ID: 1855218
[TBL] [Abstract][Full Text] [Related]
26. Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma.
Kawase I; Uemiya M; Yoshimoto T; Ogura T; Hirao F; Yamamura Y
Cancer Res; 1981 Feb; 41(2):660-6. PubMed ID: 6969630
[TBL] [Abstract][Full Text] [Related]
27. [Role of immunologic activity of host in radiotherapy].
Tsuchiya T
Gan No Rinsho; 1983 Oct; 29(13):1499-505. PubMed ID: 6608014
[TBL] [Abstract][Full Text] [Related]
28. Specific and nonspecific antitumor immunity. I. Description of an in vitro assay based on inhibition of DNA synthesis in tumor cells.
Williams RM; Germain RN; Benacerraf B
J Natl Cancer Inst; 1975 Mar; 54(3):697-708. PubMed ID: 1091740
[TBL] [Abstract][Full Text] [Related]
29. Morphological observations during developing concomitant immunity against a C3H/He mammary tumor.
Vaage J; Pepin KG
Cancer Res; 1985 Feb; 45(2):659-66. PubMed ID: 3967241
[TBL] [Abstract][Full Text] [Related]
30. Aberrant antigen presentation by macrophages from tumor-bearing mice is involved in the down-regulation of their T cell responses.
Watson GA; Lopez DM
J Immunol; 1995 Sep; 155(6):3124-34. PubMed ID: 7673727
[TBL] [Abstract][Full Text] [Related]
31. Effect of tumor cells on the generation of cytotoxic T lymphocytes in vitro. I. Accessory cell functions of mouse tumor cells in the generation of cytotoxic T lymphocytes in vitro: replacement of adherent phagocytic cells by tumor cells or 2-mercaptoethanol.
Koren HS; Hodes RJ
Eur J Immunol; 1977 Jun; 7(6):394-400. PubMed ID: 302208
[TBL] [Abstract][Full Text] [Related]
32. Immune response to a syngeneic mammary adenocarcinoma. III. Development of memory and suppressor functions modulating cellular cytotoxicity.
Kuperman O; Fortner GW; Lucas ZJ
J Immunol; 1975 Nov; 115(5):1282-7. PubMed ID: 1176776
[TBL] [Abstract][Full Text] [Related]
33. Anti-tumor cytostatic mechanism and delayed-type hypersensitivity against a syngeneic murine tumor. Comparison between neonatally thymectomized mice and congenitally athymic nude mice.
Mitani M; Mori K; Himeno K; Nomoto K
J Immunol; 1989 Mar; 142(6):2148-54. PubMed ID: 2493508
[TBL] [Abstract][Full Text] [Related]
34. Tumor-specific suppressor cells induced by immunization with spleen cells from tumor-bearing animals.
Huber SA; Bigi G; Lucas ZJ
Cancer Res; 1980 Oct; 40(10):3477-83. PubMed ID: 6449281
[TBL] [Abstract][Full Text] [Related]
35. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro.
Lynch DH; Gurish MF; Daynes RA
Immunology; 1982 Sep; 47(1):49-59. PubMed ID: 6981587
[TBL] [Abstract][Full Text] [Related]
36. Sensitization of T lymphocytes in vitro by syngeneic macrophages fed with tumor antigens.
Treves AJ; Schechter B; Cohen IR; Feldman M
J Immunol; 1976 Apr; 116(4):1059-64. PubMed ID: 1082902
[TBL] [Abstract][Full Text] [Related]
37. T-cell-mediated antitumor immune response induced by oncofetal antigens.
Gautam S; Deodhar SD
J Natl Cancer Inst; 1981 Oct; 67(4):939-45. PubMed ID: 6974275
[TBL] [Abstract][Full Text] [Related]
38. Influence of mammary tumor progression on phenotype and function of spleen and in situ lymphocytes in mice.
Buessow SC; Paul RD; Lopez DM
J Natl Cancer Inst; 1984 Jul; 73(1):249-55. PubMed ID: 6610791
[TBL] [Abstract][Full Text] [Related]
39. [Antitumor effect of OK-432 (3)--mechanisms of tumor growth inhibition by OK-432 induced activated macrophages].
Nanjo M; Saito M; Aonuma E; Fujimura H; Nakamura T; Aso H; Yoshie O; Ebina T; Ishida N
Gan To Kagaku Ryoho; 1985 Apr; 12(4):887-93. PubMed ID: 3885861
[TBL] [Abstract][Full Text] [Related]
40. Cytostatic effect of spleen cells of tumor-bearing mice on syngenetic tumor cells.
Lespinats G; Poupon MF
Cancer Res; 1977 Jun; 37(6):1727-32. PubMed ID: 870185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
